Please login to the form below

Not currently logged in
Email:
Password:

Baxter reveals collaboration for next-generation home haemodialysis

Baxter collaborates with DEKA Research & Development and HHD for the development of a next-generation home haemodialysis machine

Baxter International has collaborated with DEKA Research & Development and HHD for the development of a next-generation home haemodialysis machine.

Baxter and DEKA have collaborated on other successful products in the past, most notably on the design and development of Baxter's HomeChoice automated peritoneal dialysis machine.

Per the collaboration agreement, Baxter has purchased an option to acquire the assets of HHD and will fund DEKA's related R&D activities. Baxter may also make future royalty payments to DEKA. Baxter expects to record a special net pre-tax charge of up to USD 25m (USD 0.04 per diluted share) for in-process R&D associated with this transaction in Q3 2007.

Bruce McGillivray, president of Baxter's renal business, said: "This collaboration highlights Baxter's ongoing commitment to innovation in end-stage renal disease (ESRD) treatment. Our global leadership in home dialysis therapy, combined with DEKA's new medical product development expertise, will allow us to advance this promising technology at a faster pace."

7th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics